Blood Screening Market - Global Market Share, Trends, Analysis and Forecasts, 2023 - 2032
The market for blood screening was valued at US$ 2.3 billion in 2021 and is anticipated to grow at a CAGR of 7.7% from 2023 to 2032.
Growing awareness regarding blood donation, increasing requirement of healthy blood form clinical applications, prevalence of infectious diseases, rising number of surgical procedures, and stringent regulations to monitor blood quality are the primary forces shaping the global blood screening market. Advancement in clinical research has helped in identifying new pathogens responsible for infectious diseases, which is expected to contribute towards the growth of blood screening market in coming years.
The awareness regarding blood donation is spreading in the mid-income and low-income countries owing to the government offered incentives for blood donation. This has increased the volume of donated blood and has in turn encouraged the adoption of blood screening process to ensure the absence of infection markers.
Increase in the volume of surgeries has resulted in high demand for healthy blood to cope up with blood loss during the surgical procedures. This has fueled the demand for efficient blood screening methods. Consequently, the global blood screening market is expected to witness prominent growth during the forecast period.
North America contributed the largest share to the global blood screening market in 2019 and is expected to witness prominent growth during the forecast period. Prevalence of infectious diseases, rising demand for healthy blood, and growth in volume of donated blood are the key factors contributing towards the growth of North America blood screening market.
Presence of leading product manufacturers, and increasing investment in product innovation is expected to drive the growth of blood screening market in North America. Asia Pacific is expected to be the fastest growing market during the forecast period. Expansion of healthcare infrastructure, spreading awareness regarding blood donation, and prevalence of infectious diseases are the key factors contributing towards the growth of Asia Pacific blood screening market.
The report titled “Blood Screening Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global blood screening market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Becton, Dickinson and Company reported revenues of USD 17.3 billion in 2019 and the product segment analysis of the company indicates that BD Medical business segment of the company dominated revenue in 2019.
The global blood screening market is segmented based on component, technology, end user, and geography. Based on component, the global blood screening market is segmented into reagents & kits, instruments, software, and services. Based on technology, the global blood screening market is segmented into nucleic acid amplification test (NAT), enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), enzyme immunoassay (EIA), next-generation sequencing (NGS), western blotting, and others. Based on end user, the global blood screening market is segmented into blood banks, hospitals, and others. Based on geography, the global blood screening market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on blood screenings. Further, market share of prominent companies in the global blood screening market would also be estimated.
For instance, Becton, Dickinson and Company operates through three business segments namely BD Medical, BD Life Sciences, and BD Interventional. The Blood Screening products are delivered under BD Medical business segment of the company with revenue contribution of US$ 9.1 billion in 2019.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the blood screening reagent and product manufacturers. The global blood screening market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the blood screening business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global blood screening market.
Major players active in the global blood screening market include Abbott Laboratories, Beckman Coulter (Danaher Corporation), Becton Dickinson and Company, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Grifols, S.A., Ortho Clinical Diagnostics, Siemens, and Thermo Fisher Scientific.
Market Segmentation:
By Technology
- Nucleic Acid Amplification Test (NAT)
- ELISA
- Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
By Product
- Reagent
- Instrument
By Geography:
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
- Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
- Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
- Market Synopsis: Global Blood Screening Market
- Global Blood Screening Market Qualitative Analysis
- Trends
- Market trends
- Technology Trends
- PESTLE Analysis (For 5 prominent countries)
- Market Influencers
- Driving Forces
- Hindering Forces
- Opportunities
- COVID-19 consequences
- Trends
- Global Blood Screening Market Analysis and Forecast, by Component
- Overview and definitions
- Key segment analysis
- Global Blood Screening Market Size Estimates (US$ Mn), by Component, 2019 – 2032
- Reagents & Kits
- Instruments
- Global Blood Screening Market Analysis and Forecast, by Technology
- Overview and definitions
- Key segment analysis
- Global Blood Screening Market Size Estimates (US$ Mn), by Technology, 2019 – 2032
- Nucleic Acid Amplification Test (NAT)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
- Others
- Global Blood Screening Market Analysis and Forecast, by End Use Industry
- Overview and definitions
- Key segment analysis
- Global Blood Screening Market Size Estimates (US$ Mn), by End Use Industry, 2019 – 2032
- Blood Banks
- Hospitals
- Others
- Global Blood Screening Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Blood Screening Market Size Estimates (US$ Mn), by Region, 2019 – 2032
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
- North America Blood Screening Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Blood Screening Market Size Estimates (US$ Mn), by Component, 2019 – 2032
- Reagents & Kits
- Instruments
- North America Blood Screening Market Size Estimates (US$ Mn), by Technology, 2019 – 2032
- Nucleic Acid Amplification Test (NAT)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
- Others
- North America Blood Screening Market Size Estimates (US$ Mn), by End Use Industry, 2019 – 2032
- Blood Banks
- Hospitals
- Others
- North America Blood Screening Market Size Estimates (US$ Mn), Country, 2019 – 2032
- The U.S.
- Canada
- Rest of North America
- Europe Blood Screening Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Blood Screening Market Size Estimates (US$ Mn), by Component, 2019 – 2032
- Reagents & Kits
- Instruments
- Europe Blood Screening Market Size Estimates (US$ Mn), by Technology, 2019 – 2032
- Nucleic Acid Amplification Test (NAT)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
- Others
- Europe Blood Screening Market Size Estimates (US$ Mn), by End Use Industry, 2019 – 2032
- Blood Banks
- Hospitals
- Others
- Europe Blood Screening Market Size Estimates (US$ Mn), Country, 2019 – 2032
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific Blood Screening Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Blood Screening Market Size Estimates (US$ Mn), by Component, 2019 – 2032
- Reagents & Kits
- Instruments
- Asia Pacific Blood Screening Market Size Estimates (US$ Mn), by Technology, 2019 – 2032
- Nucleic Acid Amplification Test (NAT)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
- Others
- Asia Pacific Blood Screening Market Size Estimates (US$ Mn), by End Use Industry, 2019 – 2032
- Blood Banks
- Hospitals
- Others
- Asia Pacific Blood Screening Market Size Estimates (US$ Mn), Country, 2019 – 2032
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa Blood Screening Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Blood Screening Market Size Estimates (US$ Mn), by Component, 2019 – 2032
- Reagents & Kits
- Instruments
- Middle East & Africa Blood Screening Market Size Estimates (US$ Mn), by Technology, 2019 – 2032
- Nucleic Acid Amplification Test (NAT)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
- Others
- Middle East & Africa Blood Screening Market Size Estimates (US$ Mn), by End Use Industry, 2019 – 2032
- Blood Banks
- Hospitals
- Others
- Middle East & Africa Blood Screening Market Size Estimates (US$ Mn), Country, 2019 – 2032
- Saudi Arabia
- South Africa
- UAE
- Rest of Middle East
- South America Blood Screening Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Blood Screening Market Size Estimates (US$ Mn), by Component, 2019 – 2032
- Reagents & Kits
- Instruments
- South America Blood Screening Market Size Estimates (US$ Mn), by Technology, 2019 – 2032
- Nucleic Acid Amplification Test (NAT)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
- Others
- South America Blood Screening Market Size Estimates (US$ Mn), by End Use Industry, 2019 – 2032
- Blood Banks
- Hospitals
- Others
- South America Blood Screening Market Size Estimates (US$ Mn), Country, 2019 – 2032
- Brazil
- Rest of South America
- Competition Analysis – Blood Screening Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
- Abbott Laboratories
- Business overview
- Geographic presence
- Financial facts
- Channel partners
- Relevant news and strategic view
- Beckman Coulter (Danaher Corporation)
- Becton Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd
- Grifols, S.A.
- Ortho Clinical Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific
- Abbott Laboratories
- Conclusion & Recommendations
Frequently asked questions about this report
What are the major driving factors and opportunities in the blood screening market?
Growing awareness regarding blood donation, increasing requirement of healthy blood form clinical applications, prevalence of infectious diseases, rising number of surgical procedures, and stringent regulations to monitor blood quality are the primary forces shaping the global blood screening market.
Which segment accounted for the largest blood screening market share?
North America contributed the largest share to the global blood screening market in 2019 and is expected to witness prominent growth during the forecast period. Prevalence of infectious diseases, rising demand for healthy blood, and growth in volume of donated blood are the key factors contributing towards the growth of North America blood screening market.
What are the different technology's of blood screening used?
Based on technology, the blood screening market is segmented into nucleic acid amplification test (NAT), enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), enzyme immunoassay (EIA), next-generation sequencing (NGS), western blotting, and others.
What are the top players active in the blood screening Market?
The major active players are Abbott Laboratories, Beckman Coulter (Danaher Corporation), Becton Dickinson and Company, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Grifols, S.A., Ortho Clinical Diagnostics, Siemens, and Thermo Fisher Scientific.
What is the estimated growth rate of the blood screening market?
The blood screening market is estimated to expand at a CAGR of 7.7% from 2023 to 2032.
How big is blood screening market?
The blood screening market was valued at US$ 2.3 billion in 2021.